132 related articles for article (PubMed ID: 30560880)
41. RNA-binding residues in the N-terminus of APOBEC3G influence its DNA sequence specificity and retrovirus restriction efficiency.
Bélanger K; Langlois MA
Virology; 2015 Sep; 483():141-8. PubMed ID: 25974865
[TBL] [Abstract][Full Text] [Related]
42. Small-Angle X-ray Scattering (SAXS) Measurements of APOBEC3G Provide Structural Basis for Binding of Single-Stranded DNA and Processivity.
Barzak FM; Ryan TM; Mohammadzadeh N; Harjes S; Kvach MV; Kurup HM; Krause KL; Chelico L; Filichev VV; Harjes E; Jameson GB
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146779
[TBL] [Abstract][Full Text] [Related]
43. Insight into dynamics of APOBEC3G protein in complexes with DNA assessed by high speed AFM.
Pan Y; Shlyakhtenko LS; Lyubchenko YL
Nanoscale Adv; 2019; 1(10):4016-4024. PubMed ID: 33313478
[TBL] [Abstract][Full Text] [Related]
44. Enterovirus 71 antagonizes the inhibition of the host intrinsic antiviral factor A3G.
Li Z; Ning S; Su X; Liu X; Wang H; Liu Y; Zheng W; Zheng B; Yu XF; Zhang W
Nucleic Acids Res; 2018 Nov; 46(21):11514-11527. PubMed ID: 30247716
[TBL] [Abstract][Full Text] [Related]
45. Moloney leukemia virus 10 (MOV10) inhibits the degradation of APOBEC3G through interference with the Vif-mediated ubiquitin-proteasome pathway.
Chen C; Ma X; Hu Q; Li X; Huang F; Zhang J; Pan T; Xia J; Liu C; Zhang H
Retrovirology; 2017 Dec; 14(1):56. PubMed ID: 29258557
[TBL] [Abstract][Full Text] [Related]
46. Zinc-mediated binding of a low-molecular-weight stabilizer of the host anti-viral factor apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G.
Radwan MO; Sonoda S; Ejima T; Tanaka A; Koga R; Okamoto Y; Fujita M; Otsuka M
Bioorg Med Chem; 2016 Sep; 24(18):4398-4405. PubMed ID: 27475536
[TBL] [Abstract][Full Text] [Related]
47. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
Russell RA; Pathak VK
J Virol; 2007 Aug; 81(15):8201-10. PubMed ID: 17522216
[TBL] [Abstract][Full Text] [Related]
48. T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity.
Thielen BK; Klein KC; Walker LW; Rieck M; Buckner JH; Tomblingson GW; Lingappa JR
PLoS Pathog; 2007 Sep; 3(9):1320-34. PubMed ID: 17892323
[TBL] [Abstract][Full Text] [Related]
49. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z; Zhang W; Chen G; Xu R; Yu XF
J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
[TBL] [Abstract][Full Text] [Related]
50. USP49 potently stabilizes APOBEC3G protein by removing ubiquitin and inhibits HIV-1 replication.
Pan T; Song Z; Wu L; Liu G; Ma X; Peng Z; Zhou M; Liang L; Liu B; Liu J; Zhang J; Zhang X; Huang R; Zhao J; Li Y; Ling X; Luo Y; Tang X; Cai W; Deng K; Li L; Zhang H
Elife; 2019 Aug; 8():. PubMed ID: 31397674
[TBL] [Abstract][Full Text] [Related]
51. Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myeloma.
Talluri S; Samur MK; Buon L; Kumar S; Potluri LB; Shi J; Prabhala RH; Shammas MA; Munshi NC
Blood Cancer J; 2021 Oct; 11(10):166. PubMed ID: 34625538
[TBL] [Abstract][Full Text] [Related]
52. Polymorphisms in the APOBEC3G gene of Chinese rhesus macaques affect resistance to ubiquitination and degradation mediated by HIV-2 Vif.
Jiang ZQ; Yao XR; Yu H; Lu YE; Liu BL; Liu FL; Jin YB; Zhuo M; Zheng YT; Ling F
Arch Virol; 2019 May; 164(5):1353-1360. PubMed ID: 30859472
[TBL] [Abstract][Full Text] [Related]
53. High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition.
Chiu YL; Witkowska HE; Hall SC; Santiago M; Soros VB; Esnault C; Heidmann T; Greene WC
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15588-93. PubMed ID: 17030807
[TBL] [Abstract][Full Text] [Related]
54. Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G.
Rose KM; Marin M; Kozak SL; Kabat D
AIDS Res Hum Retroviruses; 2005 Jul; 21(7):611-9. PubMed ID: 16060832
[TBL] [Abstract][Full Text] [Related]
55. Molecular Model for the Surface-Catalyzed Protein Self-Assembly.
Pan Y; Banerjee S; Zagorski K; Shlyakhtenko LS; Kolomeisky AB; Lyubchenko YL
J Phys Chem B; 2020 Jan; 124(2):366-372. PubMed ID: 31867969
[TBL] [Abstract][Full Text] [Related]
56. The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation.
Valera MS; de Armas-Rillo L; Barroso-González J; Ziglio S; Batisse J; Dubois N; Marrero-Hernández S; Borel S; García-Expósito L; Biard-Piechaczyk M; Paillart JC; Valenzuela-Fernández A
Retrovirology; 2015 Jun; 12():53. PubMed ID: 26105074
[TBL] [Abstract][Full Text] [Related]
57. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
[TBL] [Abstract][Full Text] [Related]
58. Characterization of the Deamination Coupled with Sliding along DNA of Anti-HIV Factor APOBEC3G on the Basis of the pH-Dependence of Deamination Revealed by Real-Time NMR Monitoring.
Kamba K; Nagata T; Katahira M
Front Microbiol; 2016; 7():587. PubMed ID: 27199921
[TBL] [Abstract][Full Text] [Related]
59. Moderate sensitivity of mouse mammary tumour virus to inhibition by human APOBEC3G.
Konstantoulas CJ; Hagen B; Indik S
J Gen Virol; 2017 Sep; 98(9):2362-2367. PubMed ID: 28809145
[TBL] [Abstract][Full Text] [Related]
60. STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-alpha.
Sarkis PT; Ying S; Xu R; Yu XF
J Immunol; 2006 Oct; 177(7):4530-40. PubMed ID: 16982890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
